Biotransformation of cinobufagin by Cunninghamella elegans

Journal of Antibiotics

Volumn 60, Issue 4, 2007, Pages 261-264

  Qiao, Li ^a   Zhou, Yu Zhi ^a   Qi, Xiu Lan ^a   Lin, Li Hong ^a   Chen, Huan ^a   Pang, Li Yan ^a   Pei, Yue Hu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

11 hydroxybufagin; 12 hydroxybufagin; Biotransformation; Cinobufagin; Cunninghamella elegans

Indexed keywords

11ALPHA HYDROXYBUFAGIN; 12ALPHA HYDROXYBUFAGIN; 12BETA HYDROXYBUFAGIN; 12BETA HYDROXYDESACETYLCINOBUFAGIN; 3 OXO 12ALPHA HYDROXYBUFAGIN; CINOBUFAGIN; DIMETHYL SULFOXIDE; DRUG METABOLITE; UNCLASSIFIED DRUG; BUFADIENOLIDE DERIVATIVE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CUNNINGHAMELLA ELEGANS; CYTOTOXICITY; DRUG DISCRIMINATION; DRUG ISOLATION; DRUG STRUCTURE; DRUG TRANSFORMATION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; BIOTRANSFORMATION; CELL SURVIVAL; CUNNINGHAMELLA; DRUG EFFECT; METABOLISM; STRUCTURE ACTIVITY RELATION;

CUNNINGHAMELLA ELEGANS;

BIOTRANSFORMATION; BUFANOLIDES; CELL SURVIVAL; CUNNINGHAMELLA; HELA CELLS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34547195889     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2007.32     Document Type: Article

References (11)

1. Ye M, Han J, Guo HZ, Guo DA. Structural determination and complete NMR spectral assignments of a new bufadienolide glycoside. Magn Reson Chem 40: 786-788 (2002)
2. Krenn L, Kopp B. Bufadienolides from animal and plant sources. Phytochemistry 48: 1-29 (1998)
3. Steyn PS, Heerden FR. Bufadienolides of plant and animal origin. Nat Prod Rep 15: 397-413 (1998)
4. Nogawa T, Kamano Y, Yamashita A, Pettit GR. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su. J Nat Prod 64: 1148-1152 (2001)
5. Wang JH, Jin W, Jin HY, Zhou FR. Induction by bufalin od differentiation of human leukemia cells HL60, U937 and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. China J Chin Mater Med 23: 651-653 (1998)
6. Ning LL, Guo HZ, Jiang XM, Bi KS, Guo DA. Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Pure Appl Chem 75: 389-392 (2003)
7. Dai JG, Guo HZ, Lu DD, Zhu WH, Zhang DY, Zheng JH, Guo DA. Biotransformation of 2,5,10,14-tetra-acetoxy-4(20),11-taxadiene by Ginkgo cell suspension cultures. Tetrahedron Lett 42: 4677-4679 (2001)
8. Ye M, Dai JG, Guo HZ, Guo DA. Glucosylation of cinobufagin by cultured suspension cells of Catharanthus roseus. Tetrahedron Lett 43: 8535-8538 (2002)
9. Ye M, Qu GQ, Guo HZ, Guo DA. Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships. J Steroid Biochem Mol Biol 91: 87-98 (2004)
10. Ye M, Qu GQ, Guo HZ, Guo DA. Specific 12-hydroxylation of cinobufagin by filamentous fungi. Appl Env Micro 70(6): 3521-3527 (2004)
11. Vercammen D, Beyaert R, Denecker G, Goossens V, Loo GV, Declercq W. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187: 1477-1485 (1998)